Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
940.3000
1.50
(
0.16
%)
NSE
May 07, 2026
15:31 PM
Volume:
488.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
22 Mar 2023
US FDA Observation
940.30
0.16%
Zydus Life
Buy:
Zydus Lifesciences Ltd.
by
Sharekhan
Target: 572
Target
Sharekhan
Zydus Lifesciences Ltd. is trading
above its 150 day SMA
of 926.2
More from Zydus Lifesciences Ltd.
Recommended
Market closes flat as caution persists amid foreign fund outflows
Trendlyne Marketwatch |
07 May 2026, 03:57PM
What drove multibaggers in FY26: Order books, commodity cycles and turnaround plays
The Baseline |
07 May 2026, 01:14PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020